Altrinsic Global Advisors LLC Intercept Pharmaceuticals, Inc. Transaction History

Altrinsic Global Advisors LLC

$2.13 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $2.26 Million - $3 Million	-168,800 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$19.33 - $37.75 $2.83 Million - $5.53 Million	-146,430 Reduced 46.45%	168,800 $3.9 Million
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $689,234 - $1.2 Million	28,155 Added 9.81%	315,230 $7.79 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $278,828 - $381,187	7,133 Added 2.55%	287,075 $11.9 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $266,049 - $524,351	-5,697 Reduced 1.99%	279,942 $13.4 Million

Q1 2020 May 14, 2020	SELL	$48.35 - $118.68 $246,198 - $604,318	-5,092 Reduced 1.75%	285,639 $18 Million
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $980,683 - $2.12 Million	-17,097 Reduced 5.55%	290,731 $36 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $1.5 Million - $2.05 Million	25,474 Added 9.02%	307,828 $20.4 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $112,766 - $174,986	1,450 Added 0.52%	282,354 $22.5 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $271,816 - $357,212	2,960 Added 1.06%	280,904 $31.4 Million
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $2.98 Million - $4.39 Million	-34,683 Reduced 11.09%	277,944 $28 Million
Q3 2018 Nov 14, 2018	SELL	$88.49 - $127.55 $6.24 Million - $9 Million	-70,539 Reduced 18.41%	312,627 $39.5 Million
Q2 2018 Aug 13, 2018	BUY	$60.0 - $85.67 $476,580 - $680,476	7,943 Added 2.12%	383,166 $32.2 Million
Q1 2018 May 14, 2018	BUY	$52.72 - $67.25 $3.42 Million - $4.37 Million	64,923 Added 20.92%	375,223 $23.1 Million
Q4 2017 Feb 13, 2018	BUY	$58.2 - $72.76 $4.53 Million - $5.66 Million	77,756 Added 33.44%	310,300 $18.1 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $13.3 Million - $27.6 Million	232,544	232,544 $13.5 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.

Account